Found 6 results
↓ CSVName | Type of Offering | Accepted Date |
---|---|---|
Euclidean Fund For Cancer Research LP
See All Filings
|
D/A | 2022-10-04 13:39:26 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001729236
Filed Document
0000919574-22-005772
Exclusions or Exemptions
506c
Accepted Date
2022-10-04 13:39:26
Type of Offering
D/A
Industry
Pooled Investment Fund
Offering Tier
N/A
Principal Place of Business
WASHINGTON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Euclidean Fund For Cancer Research LP
See All Filings
|
D | 2018-05-01 13:38:02 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001729236
Filed Document
0000919574-18-003237
Exclusions or Exemptions
506c
Accepted Date
2018-05-01 13:38:02
Type of Offering
D
Industry
Pooled Investment Fund
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Euclidean Fund For Cancer Research LP
See All Filings
|
D/A | 2021-10-07 15:31:40 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001729236
Filed Document
0000919574-21-006153
Exclusions or Exemptions
506c
Accepted Date
2021-10-07 15:31:40
Type of Offering
D/A
Industry
Pooled Investment Fund
Offering Tier
N/A
Principal Place of Business
WASHINGTON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Euclidean Fund For Cancer Research LP
See All Filings
|
D/A | 2019-05-01 12:06:22 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001729236
Filed Document
0000919574-19-003082
Exclusions or Exemptions
506c
Accepted Date
2019-05-01 12:06:22
Type of Offering
D/A
Industry
Pooled Investment Fund
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Euclidean Fund For Cancer Research LP
See All Filings
|
D/A | 2019-10-07 15:22:59 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001729236
Filed Document
0000919574-19-006264
Exclusions or Exemptions
506c
Accepted Date
2019-10-07 15:22:59
Type of Offering
D/A
Industry
Pooled Investment Fund
Offering Tier
N/A
Principal Place of Business
WASHINGTON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Euclidean Fund For Cancer Research LP
See All Filings
|
D/A | 2020-10-07 12:03:06 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001729236
Filed Document
0000919574-20-006214
Exclusions or Exemptions
506c
Accepted Date
2020-10-07 12:03:06
Type of Offering
D/A
Industry
Pooled Investment Fund
Offering Tier
N/A
Principal Place of Business
WASHINGTON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|